SCHEMBL4281995

SCHEMBL4281995

CCCC[CH]NC(=N)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6373292 0.93 SPHK2 (0.41)
SCHEMBL9252230 0.91 SPHK2 (0.45)
Hydrochloric Acid SCHEMBL28273045 0.90 SPHK1 (0.43)
SCHEMBL2494175 0.86
SCHEMBL245695 0.78
SCHEMBL8006098 0.77
SCHEMBL5765981 0.73 FAAH (0.49)
SCHEMBL15778751 0.71
SCHEMBL1415923 0.71 FAAH (0.48)
SCHEMBL11802684 0.71 FAAH (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150031743-A1 CELL TRANSFECTING FORMULATIONS OF SMALL INTERFERING RNA, RELATED COMPOSITIONS AND METHODS OF MAKING AND USE NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2015-01-29 US disclosed
US-8772255-B2 Cell transfecting formulations of small interfering RNA related compositions and methods of making and use NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2014-07-08 US disclosed
EP-1709195-B1 CELL TRANSFECTING FORMULATIONS OF SMALL INTERFERING RNA, RELATED COMPOSITIONS AND METHODS OF MAKING AND USE NOVARTIS VACCINES & DIAGNOSTIC (US) 2014-01-22 EP disclosed
US-20090143322-A1 CELL TRANSFECTING FORMULATIONS OF SMALL INTERFERING RNA RELATED COMPOSITIONS AND METHODS OF MAKING AND USE CHIRON CORPORATION (US) 2009-06-04 US disclosed
US-7214384-B2 Lipid-conjugated polyamide compounds NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2007-05-08 US disclosed
EP-1709195-A2 CELL TRANSFECTING FORMULATIONS OF SMALL INTERFERING RNA, RELATED COMPOSITIONS AND METHODS OF MAKING AND USE CHIRON CORPORATION (US) 2006-10-11 EP disclosed
US-20060019912-A1 Cell transfecting formulations of small interfering RNA related compositions and methods of making and use CHIRON CORPORATION 2006-01-26 US disclosed
US-6982092-B2 Method of complexing a nucleic acid with a lipid-conjugated polyamide CHIRON CORPORATION (US) 2006-01-03 US disclosed
US-20050181988-A1 Echinocandin cyclic peptide derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-08-18 US disclosed
WO-2005060697-A2 CELL TRANSFECTING FORMULATIONS OF SMALL INTERFERING RNA, RELATED COMPOSITIONS AND METHODS OF MAKING AND USE CHIRON CORPORATION (US) 2005-07-07 WO disclosed
US-5264457-A Phenyl amidines sulfonamides useful as platelet aggregation inhibitors G. D. SEARLE & CO. (US) 1993-11-23 US disclosed
WO-1993016038-A1 PHENYL AMIDINES SULFONAMIDES USEFUL AS PLATELET AGGREGATION INHIBITORS G. D. SEARLE & CO. (US) 1993-08-19 WO disclosed
WO-1993014113-A1 PEPTIDES WITH TACHYKININ ANTAGONIST ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-07-22 WO disclosed
WO-1993012103-A1 PHENYL AMIDINES LACTONES USEFUL AS PLATELET AGGREGATION INHIBITORS G.D. SEARLE & CO. (US) 1993-06-24 WO disclosed
WO-1993012074-A1 PEPTIDE MIMETIC COMPOUNDS USEFUL AS PLATELET AGGREGATION INHIBITORS G.D. SEARLE & CO. (US) 1993-06-24 WO disclosed
US-5220050-A PEPTIDE MIMETIC COMPOUNDS USEFUL AS PLATELET AGGREGATION INHIBITORS G. D. SEARLE & CO. (US) 1993-06-15 US disclosed
WO-1992020705-A1 PEPTIDE MIMETIC COMPOUNDS USEFUL AS PLATELET AGGREGATION INHIBITORS G.D. SEARLE & CO. (US) 1992-11-26 WO disclosed
EP-0513810-A1 Peptide mimetic compounds useful as platelet aggregation inhibitors G.D. Searle & Co. (US) 1992-11-19 EP disclosed
WO-1992015607-A2 PHENYL AMIDINES DERIVATIVES USEFUL AS PLATELET AGGREGATION INHIBITORS G.D. SEARLE & CO. (US) 1992-09-17 WO disclosed
EP-0502536-A1 Phenyl amidines derivatives useful as platelet aggregation inhibitors G.D. Searle & Co. (US) 1992-09-09 EP disclosed